Suzhou Highfine Biotech Targets 1.8 Billion Yuan from Shenzhen IPO-- Suzhou Highfine Biotech is looking to raise up to 1.83 billion yuan from its initial public offering on the Shenzhen Stock Exchange’s ChiNext board. The Chinese producer of peptide chemicals and...